Home

Lincoln Alternative Strategies reported a 14.46% stake in Calidi Biotherapeutics CLDI · 730,000 sh · passive holder

Trade details

Type
5% stake report
Report
13G passive
Stake
14.46%
Last report
First report
Shares held
730,000 sh
Class
Common Stock, $0.0001 par value
Event date
25/08/20
Filed
25/08/27

First 5%+ report · 14.46% stake

Calidi Biotherapeutics trades, last 26 weeks

What else happened in Calidi Biotherapeutics around then

Filed or reported within 30 days of the trade day · 25/07/21~25/09/19

Lincoln Alternative Strategies's other 5% stake reports